Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I have always respected your posts eicoman even when we disagreed. And our disagreement has been more around Apricus management and the viability of the Vitaros product.
There is no need to apologize for your view of Apricus or any opinion expressed here. There are many hard lessons to be learned from investing in the markets let alone speculative companies. The simple truth is most biopharmaceutical companies either fail or continue to spin their stories and destroy shareholder value.
I for one never bought APRI because of anything you or anyone else posted here. I used this blog as ONE resource for helping me decide to speculatively invest my money. And once I was convinced (by the actions of management, conference calls, and 10Q/10K reports) the risk was too high at the current PPS, I closed out my position.
Good luck to you.
Thanks for this eicoman. But as I mentioned in a previous post, what's missing from all this reporting is repeat purchases. While this level of detail is difficult to obtain, it would be a great statistic (if positive of course) to share with all stakeholders.
It's usually not what you know that can hurt you in life (investing or otherwise). It's what you don't know.
Here is simple reasoning. IF they think the PPS will go UP (just like you and me), they should BUY the shares. Even if they already own a chunk they could offload shares (just like you and me) once the PPS goes UP. They have more restrictions on buy/sell but it can be done.
Buy low, sell high. It's the same for all traders/investors/insiders (if you are long the stock).
And don't use ANY of their own money mecosmo2. That's they key point. Those are options and most likely they can buy shares cheaper today.
Given Execs and BODs have basically destroyed shareholder value they don't deserve ANY of those shares so far.
Yes it can in some cases. They cannot buy/sell based on non-public information (that could impact the PPS) AND the SEC would have to prove this IF they pursue a case.
So for almost 2 years he couldn't find a window to buy APRI stock? And now that they have disclosed their short term Vitaros plans he still can't buy?
They can also create plans to buy/sell stock in advance. Hasn't done that either.
Added a bit more at .36.
I think the bad news on this is out for now. I'd add more IF I saw insider buying. The last time Pascoe bought APRI stock was 10/2014.
It's clear APRI management and BOD think there is high risk even at these low PPS levels.
I thought I saw in an earlier post someone quoting 3 days at room temp, not 7. Is it 3 or 7?
Of particular interest to me with respect to sales would be new vs. repeat. If patients buy and continue to buy Vitaros, that says more than anything about patient level satisfaction. As an investor one would hope the decline in sales is only what the company is telling us (lack of effort, marketing, product issues, etc.).
You would think APRI would want to know this as well. And if the news is positive (high % of current patients repurchase), this would help drive PPS.
Quite a ramble for someone who has now posted twice about APRI on the Hub. Didn't see anything about "fatman and team" recommending APRI at higher levels. But given I've been around a few years here others before you have (and lived to regret it so far).
The delisting, if coming, is easily handled by a R/S. No big deal if the long term story is intact.
It doesn't take much to predict PPS on this or any other stock. The key is accuracy and credibility.
Let's keep this simple. Big sales out of Europe and/or US approval moves this one north. Technicals don't matter if this doesn't happen.
Well, there aren't many buyers due to all the historical issues with the company (management, products, agreements, etc.). When a stock is well below $1 that tells you everything about market confidence. It is a speculative traders stock for most, not a long term investment.
If sales were very strong and the company was profitable, the stock would not be .30. APRI management/BOD has no one to blame but itself for it's current set of woes and dismal stock performance.
So, the PPS does not surprise me. And I'm willing to gamble a bit on the future of APRI.
I hear you PP. I bailed on this one some time ago to cut my losses. I think it was over $1K-2K.
I think we could see some uptick before November but it will most likely trade within the .30 - .40 range. No big moves up or down unless a great next CC or major announcement.
I'm a player just gambling on this now. Ok if I lose it.
Well, it depends. Even if you aren't a trader, IF you have a better place to put your money, eat the loss and move on.
Long ago I said the real problem with loser stocks is not just the loss, but the opportunity costs. For those long the stock well above $1 they not only have losses but missed out on stocks that have appreciated. Double ouch.
The investing universe is full of other options. This is still a high risk, speculative, one-trick pony stock even with a marketable product. And in my IRA it gets .4% of my available investing dollars.
Nah, I'm good with my small position unless it breaks down into the mid-low .20s.
Yep, I"m with you. Did nicely with a swing trade from $23 to $27 after setting a stop.
It needs to settle for a bit before I go back in.
Eh, this is not genius stuff. Investing 101. Too many people on these boards watch their high risk stocks each day hoping for a pop.
APRI will pop if they get US approval or show increasing sales of Vitaros.
Yes it can even with dilution. Before I exited my previous position I posted stocks eventually rise based on fundamentals/projected growth. I also argued APRI needed to demonstrate, via revenues/sales and margin, Vitaros was a viable product.
Any current manipulation of this stock (by traders) has little to do with dilution or the "big boys" "they" are conspiring to keep the price low. The stock has been correctly battered and dumped for all the right reasons. Bad management, production issues, bad distribution agreements, broken promises to shareholders. It has very little credibility with the Street and is hanging on to it's last best hope: Vitaros.
At this point it seems FDA approval is more likely than not which is why I restarted a small position. But if you own any other companies walking the new drug approval road you'll know it can be a difficult journey.
Finally, it's surprising to me if there is a reasonable chance of approval there isn't more insider buying at these depressed prices. My guess is most options are worthless and IF management/BOD was convinced they had a winner here they would buy in. But I don't see the buys.
So, let's keep this real boys. Just as before, when the stock was much higher, there is no attempt to "keep prices low", it's not going anywhere because of dilution, blah, blah, blah. Apricus needs to move product and get US approval. Or this company is toast.
"Big boys" (institutions/mutual funds) as a rule don't buy penny stocks. I highly doubt there is any manipulation by them as this is a highly speculative, high risk traders stock.
Until they get US approval (if they do) this stock should trade in a range (well below $1).
You are, of course, not accurate here. There are countless examples of reverse splits where companies went on to higher PPS.
That is correct. A R/S does not change the book value. So it's not a reason to buy/not buy at this point. In fact, I think all the possible bad news is out (short of NDA delays) in the short run now. Hopefully this is the bottom (so this had been said before).
Yes, I'm in with my Roth and traditional IRA. Averaged in around 4.80. Don't plan to sell this one for quite some time given the rev/eps/GM growth.
Back in at .31
Might even add over the next few months. I'm fine if I lose it all. But IF they get US approval, it's at least a double I would guess.
Still lurking....
Got out some time ago and obviously glad I did. While folks here have future hope for Vitaros it's clear the market doesn't believe in it. The stock is, and has been, high risk and speculative.
As long as APRI management doesn't find a way to screw up it's last playing card this might be worth a few bucks IF it pops.
I wouldn't say "this selloff is retail traders who only got in to bet on the FDA" event. There is clearly more risk in the stock given they dropped the 5ug/kg dosage. I think I read somewhere the 5kg dosage had the highest efficacy of all the dosages.
I exited my position and took profits on a gamble the stock would continue a temporary downward trend. So far, so good. It may continue this way given no short term catalyst.
I still like this long term. Keep in mind this is clinical-stage biopharmaceutical company with no revenue or earnings which means it's speculative. Promising products, yes, but still speculative.
Just waiting for a new bottom to get back in. My guess is high $5 before it goes over $7.
So much for the rapid rise on PPS. And given they have botched the communication of this "merger" it's hard to get behind it.
Let's see what the call brings tomorrow.
Looks like a good buy. I own it in my Roth and traditional IRA.
“I'm unconcerned about the current share price. As I mentioned in a previous post I'm pleased with the progress Pascoe has made. If I'm wrong and they do dilute at these levels I think I would be best served to head for for the exits”. 11/27/15 baltimorebullet
Nuff said.
Back in around 5.20. If you do your homework on this micro you'll like what you see.
"But selling now would be a mistake". SB
Not if you have a better place to put your investment dollars. I closed my original APRI position (at a loss), moved on to PLNR (bought out by a bigger company), and did very well. I restarted a small APRI position around $1.10 but closed it after the bad news. I already know where to put the money tomorrow.
Years ago I posted the problem with APRI was not just being underwater, but the opportunity cost. For many of you this has been a very, very expensive investment. Very painful. And you still don't know APRI will realize a PPS to make it worth your while (however you define this).
In general I agree with most of what SB has posted over the years here. But on the advice to not sell, I do not. I do not, because even in the speculative stock world, I believe there are better opportunities.
Whatever you decide I hope it pays off. I have no intention of investing in APRI again. Good luck to you all.
Up 80% YTD.
It clearly was a low risk buy in the low $1 range. If they can diversify (both sales and products) we might have something here.
My only buy in my Roth looks great at a $1.41. My 401K needs this to be a bit above $3.
You've got a few things mixed up. In July of 2014 they suspended the dividend when the stock was a bit above $5 share. The reason for this, according to the PR, was to fund additional marketing of FC2 and explore other products/business opportunities. They also hired a new CEO to lead this effort.
To date, no new products, a new strategy to market FC2 direct, and the CEO was out. The stock got crushed all the way down to $1.20 or so and has risen to it's current level.
I own 10K shares in two different accounts and still a bit under water. I did add in the low $1 range to average other buys.
No, I don't think they will bring back the dividend. They are trying to make this a growth company and diversify. Let's see if they can.
Shorting, maybe. AH is up. P/S is still below 1.
I may look to set a stop and take profits after another double digit run tomorrow.
I ate the breadsticks a few weeks back. Can't honestly evaluate them as I was talking with a P5 regional manager and didn't eat them till I go home. I'm not much of a breadstick guy anyway.
Seeking Apha has a few good contributors on RAVE if you haven't seen them yet.
Buyout rumors almost always lift a stock. Here are some other reasons:
1. Last QT they beat the bottom line estimate.
2. On just a P/S ratio it was about .50 before the recent runup.
3. Technicals are now very good and it's below $5. Traders/chart watchers are in.
4. The stock was heavily shorted so shorts exited their position.
I'm on the sidelines until it cools off.
Now that everyone's excited to own GRPN it's probably time to sell.
Actually, I'm going to hold for a bit until I see how the biz develops this year. And, unlike a number of you short term traders/holders, I don't want a buyout.
I want a triple or a quad until I exit the stock.
Stocks like this can be easily manipulated in the short run. I picked up more shares today.
Not really. I assume you can read basic financial tables, yes?
I started a position on this one in the low $3 and bought more in the mid $2 range. This is a big name brand and, with the right leadership team, could turn into a big winner.
VG report today. Looks like GRPN found a bottom.
Hi 44. According to one source, since June of 2015, there has been no insider selling and nothing but purchases. 5 open market purchases for 32,000 shares and about 100,000 shares per grants.
It's my understanding RAVE sold shares last summer to raise capital for store expansion. Dilution for shareholders yet they are on an aggressive expansion path.
Given this stock is thinly traded, below $10 a share, and the company is not yet profitable, it's hard to predict share price. I'd be fine with something north of $7 in 2016, with increasing SSS and store adds.
There are many players in the fast casual pizza market. Let's see if P5 can be a big player.
I'd like to see more than your opinion on this. Reference data to support it's "dead".
Location is important for any business. I think the LT challenge is there are many players in this segment. Will P5 be one of the big 3?
The worst should be over for FHCO.
Owned this one for a few years. Added to my position near the bottom given it was oversold.
I'd like to see this one over $2 in 2016. It should be with a smart acquisition and a direct to consumer sales strategy.
I haven't followed Blaze yet, but given LJ is a big investor, I'll steer clear just on that fact alone.
I did eat lunch at the local Pie Five today. VG overall. Spoke with GM who said they've been slammed since they opened last week.
I'm taking a hard look at this one trying to decide how aggressive I should be at this point.
Hi jag. So far only this one and yahoo. I hope to get this one going.